Trial intelligence / Profile preview

Pilot study of Moviprep versus Picolax for bowel preparation before colonoscopy

2004-001487-43Phase 2Completed

Sponsor
Norgine
Start
Jun 2005
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of macrogol (2 arms), sponsored by Norgine. Primary endpoint: Overall quality of gut cleansing. Started Jun 2005; status: completed.

02

Drugs

macrogol

Beyond the preview

Go deeper on 2004-001487-43.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001487-43.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call